Original ResearchEditorial CommentAchieving Intensive Systolic Blood Pressure Control: No Reason to Delay
Editorial Comment
Full text access
Key Words
blood pressure
target trial emulation
treatment
Cited by (0)
- The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2025 by the American College of Cardiology Foundation. Published by Elsevier.